HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by Bank of America Corp DE

Bank of America Corp DE cut its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 6.3% during the 4th quarter, Holdings Channel reports. The firm owned 606,197 shares of the company’s stock after selling 40,998 shares during the period. Bank of America Corp DE’s holdings in HealthEquity were worth $58,165,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Arcadia Investment Management Corp MI acquired a new stake in HealthEquity during the fourth quarter worth approximately $26,000. Transce3nd LLC acquired a new stake in HealthEquity during the fourth quarter worth approximately $29,000. Smartleaf Asset Management LLC boosted its position in HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after acquiring an additional 98 shares during the last quarter. Proficio Capital Partners LLC acquired a new stake in HealthEquity during the fourth quarter worth approximately $39,000. Finally, UMB Bank n.a. boosted its position in HealthEquity by 65.6% during the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after acquiring an additional 164 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction on Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total value of $446,487.50. Following the transaction, the director now owns 84,969 shares of the company’s stock, valued at approximately $6,597,842.85. This trade represents a 6.34% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Michael Henry Fiore sold 8,881 shares of the firm’s stock in a transaction on Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the transaction, the executive vice president now directly owns 56,655 shares in the company, valued at approximately $4,433,820.30. This represents a 13.55% decrease in their position. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.

HealthEquity Stock Performance

NASDAQ:HQY opened at $96.99 on Wednesday. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The company has a market cap of $8.39 billion, a P/E ratio of 88.98, a P/E/G ratio of 1.60 and a beta of 0.45. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $115.59. The firm’s 50 day moving average is $87.82 and its two-hundred day moving average is $96.81.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on HQY. Raymond James upgraded shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and decreased their target price for the stock from $120.00 to $115.00 in a research report on Tuesday, March 25th. Barrington Research restated an “outperform” rating and set a $112.00 target price on shares of HealthEquity in a research report on Friday, April 11th. The Goldman Sachs Group decreased their target price on shares of HealthEquity from $107.00 to $94.00 and set a “neutral” rating on the stock in a research report on Thursday, March 27th. Wells Fargo & Company increased their price target on shares of HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 26th. Finally, KeyCorp cut their price target on shares of HealthEquity from $110.00 to $100.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 16th. One equities research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $111.75.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.